Lupin launches generic Wellbutrin XL tablets in US

15 Jun 2017 Evaluate

Lupin has launched its Bupropion Hydrochloride Extended-Release tablets USP (XL), 150 mg and 300 mg having received an approval from the United States Food and Drug Administration (USFDA) earlier.

Bupropion Hydrochloride Extended-Release tablets USP (XL), 150 mg and 300 mg is the AB rated generic equivalent of Valeant Pharmaceuticals North America, LLC's Wellbutrin XL tablets, 150 mg and 300 mg. It is indicated for the treatment of major depressive disorder (MDD) and prevention of seasonal affective disorder (SAD) in adults. As per IMS MAT May 2017, Wellbutrin XL tablets had US sales of $758 million.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2119.50 -31.55 (-1.47%)
01-Feb-2026 13:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.65
Dr. Reddys Lab 1225.20
Cipla 1318.20
Zydus Lifesciences 887.15
Lupin 2119.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×